Emergent BioSolutions Inc. (EBS)

Pharmaceutical Preparations · Healthcare · $963M

undervalued
Intrinsic Value (Consensus)
$22.45
Current Price
$18.60
Margin of Safety
+20.7%
20.7% Below Intrinsic Value
Value: $22
Price: $19

Valuation Model Estimates

Current Price: $18.60
DCF (Discounted Cash Flow)
$47.63
Graham Number
$14.53
Earnings Power Value
$9.03
Relative Value (P/E)
$18.60
Dividend Discount Model
Not applicable
Consensus Value
$22.45

Model Assumptions

Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$0.93
EPS (Forward)
$0.98
Book Value
$10.09
P/E Ratio
20.0
Forward P/E
19.0
PEG Ratio
ROE
10.1%
Debt/Equity
113%
Revenue Growth
-28.8%
Earnings Growth
5.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance